These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 21516121)

  • 1. Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.
    Chen J; Xie J; Jiang Z; Wang B; Wang Y; Hu X
    Oncogene; 2011 Oct; 30(42):4297-306. PubMed ID: 21516121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis.
    Zhao X; Zhu Y; Hu J; Jiang L; Li L; Jia S; Zen K
    Sci Rep; 2018 Sep; 8(1):14517. PubMed ID: 30266938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tumor effects of novel alkannin derivatives with potent selectivity on comprehensive analysis.
    Dai ZQ; Gao F; Zhang ZJ; Lu MJ; Luo YJ; Zhang T; Shang BX; Gu YH; Zeng Q; Gao S; Guo ZQ; Xu B; Lei HM
    Phytomedicine; 2023 Aug; 117():154912. PubMed ID: 37295023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shikonin inhibited glycolysis and sensitized cisplatin treatment in non-small cell lung cancer cells via the exosomal pyruvate kinase M2 pathway.
    Dai Y; Liu Y; Li J; Jin M; Yang H; Huang G
    Bioengineered; 2022 May; 13(5):13906-13918. PubMed ID: 35706397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shikonin differentially regulates glucose metabolism via PKM2 and HIF1α to overcome apoptosis in a refractory HCC cell line.
    Yang W; Liu J; Hou L; Chen Q; Liu Y
    Life Sci; 2021 Jan; 265():118796. PubMed ID: 33220292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2.
    Shankar Babu M; Mahanta S; Lakhter AJ; Hato T; Paul S; Naidu SR
    PLoS One; 2018; 13(2):e0191419. PubMed ID: 29394289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyruvate kinase M2 is a poor prognostic marker of and a therapeutic target in ovarian cancer.
    Chao TK; Huang TS; Liao YP; Huang RL; Su PH; Shen HY; Lai HC; Wang YC
    PLoS One; 2017; 12(7):e0182166. PubMed ID: 28753677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic and Proliferative State of Vascular Adventitial Fibroblasts in Pulmonary Hypertension Is Regulated Through a MicroRNA-124/PTBP1 (Polypyrimidine Tract Binding Protein 1)/Pyruvate Kinase Muscle Axis.
    Zhang H; Wang D; Li M; Plecitá-Hlavatá L; D'Alessandro A; Tauber J; Riddle S; Kumar S; Flockton A; McKeon BA; Frid MG; Reisz JA; Caruso P; El Kasmi KC; Ježek P; Morrell NW; Hu CJ; Stenmark KR
    Circulation; 2017 Dec; 136(25):2468-2485. PubMed ID: 28972001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antitumor activity of novel 2, 3-didithiocarbamate substituted naphthoquinones as inhibitors of pyruvate kinase M2 isoform.
    Ning X; Qi H; Li R; Jin Y; McNutt MA; Yin Y
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):126-129. PubMed ID: 29185365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination Treatment Using Pyruvate Kinase M2 Inhibitors for the Sensitization of High Density Triple-negative Breast Cancer Cells.
    Lee JS; Oh Y; Lee JS; Park JH; Shin JK; Han JH; Kim HS; Yoon S
    In Vivo; 2022; 36(5):2105-2115. PubMed ID: 36099094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of small molecule inhibitors of pyruvate kinase M2.
    Vander Heiden MG; Christofk HR; Schuman E; Subtelny AO; Sharfi H; Harlow EE; Xian J; Cantley LC
    Biochem Pharmacol; 2010 Apr; 79(8):1118-24. PubMed ID: 20005212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor M2-PK: A novel urine marker of bladder cancer.
    Liu W; Woolbright BL; Pirani K; Didde R; Abbott E; Kaushik G; Martin P; Hamilton-Reeves J; Taylor JA; Holzbeierlein JM; Anant S; Lee EK
    PLoS One; 2019; 14(6):e0218737. PubMed ID: 31246990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin.
    Wang X; Zhang F; Wu XR
    Sci Rep; 2017 Apr; 7():45983. PubMed ID: 28378811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shikonin inhibits growth, invasion and glycolysis of nasopharyngeal carcinoma cells through inactivating the phosphatidylinositol 3 kinase/AKT signal pathway.
    Zhang J; Zhou J; Xiao S
    Anticancer Drugs; 2020 Oct; 31(9):932-941. PubMed ID: 32282369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines.
    Thonsri U; Seubwai W; Waraasawapati S; Wongkham S; Boonmars T; Cha'on U; Wongkham C
    Anticancer Res; 2020 Sep; 40(9):5115-5124. PubMed ID: 32878800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of novel alkannin and shikonin oxime derivatives as potent antitumor agents.
    Wang R; Zhang X; Song H; Zhou S; Li S
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4304-7. PubMed ID: 25127868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis.
    Wang Y; Hao F; Nan Y; Qu L; Na W; Jia C; Chen X
    Int J Biol Sci; 2018; 14(13):1883-1891. PubMed ID: 30443191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pyruvate kinase M2-regulating aerobic glycolysis on chemotherapy resistance of estrogen receptor-positive breast cancer.
    Qian Y; Bi L; Yang Y; Wang D
    Anticancer Drugs; 2018 Aug; 29(7):616-627. PubMed ID: 29782350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel naphthoquinone derivatives as inhibitors of the tumor cell specific M2 isoform of pyruvate kinase.
    Ning X; Qi H; Li R; Li Y; Jin Y; McNutt MA; Liu J; Yin Y
    Eur J Med Chem; 2017 Sep; 138():343-352. PubMed ID: 28688274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis.
    Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.